Author: Ashley Aguillard Editor: Michaela Price This article will cover a well-known class of drugs for type 2 diabetes (T2D), GLP-1 receptor agonists
This ensures that even minor side effects are managed swiftly and safely
J Biol Chem 275:4006440072 Engel AG, Rebouche CJ, Wilson DM, Glasgow AM, Romshe CA, Cruse RP (1981) Primary systemic carnitine deficiency
Key properties: Does not increase cortisol important for avoiding stress hormone elevation Does not increase prolactin no hormonal disruption Minimal ghrelin-like hunger suitable when appetite stimulation is unwanted Dose-dependent GH release predictable, linear response This selectivity makes Ipamorelin the go-to choice when a clean GH pulse is the primary goal without metabolic side effects
Another regulator, TRIM21, binds to FSP1 through its PRY-SPRY domain and mediates K63 ubiquitination, facilitating FSP1 translocation to the plasma membrane